Today, artificial intelligence (AI) has seamlessly coalesced into the lives of humans. As a matter of fact, AI has altered the way people connect to technology and to others. But what would be the impact of AI when it comes to medicine?
With modern technology's ubiquity, artificial intelligence is deemed as a great asset, particularly in the broad and expansive field of medicine. AI's collaboration with medicine is nothing new and surprising but very promising, with data-driven medicine as the "next frontier" in healthcare revolution.
What Is Data-Driven Medicine?
People have already an idea when it comes to artificial intelligence and precision medicine. But what exactly is data driven medicine? According to Forbes, AI for data-driven medicine has the "ability to improve the speed and accuracy" of genetic disease diagnoses, as well as the ability to open personalized medical treatments possibilities.
SOPHiA: The World's Most Advanced Collective Artificial Intelligence Platform For Data-Driven Medicine
As healthcare consumers become more committed to know more about their own medical treatment, data-driven medicine global leader and Swiss company Sophia Genetics has built a collective artificial intelligence platform for data-driven medicine known as SOPHiA. With the combination of "AI, genome data with analysis, medical science and expert opinion," SOPHiA can create a diagnosis that will assist healthcare experts in personalizing a patient's treatment.
How SOPHiA's Artificial Intelligence For Data-Driven Medicine Revolutionizes Healthcare And Disease Diagnosis
In addition, SOPHiA can also "read and aggregate" DNA's genetic code and predict or diagnose genetic diseases including cancer. With SOPHiA, those months-long medical testing will no longer exist as the artificial intelligence for data-driven medicine could allow patients to be tested for various diseases at the same time, with results availability in just a matter of hours.
With that said, Sophia Genetics CEO and cofounder Jurgi Camblong stressed that SOPHiA will allow healthcare professionals to identify more "life-threatening diseases" and to diagnose more patients than usual. Due to SOPHiA's state-of-the-art artificial intelligence technology, it's currently considered as "world's largest clinical genomics community for molecular diagnostics," with a collection of 170 hospitals from 28 countries to date.
"Sophia Genetics is the first company with such genomic variant classification power in molecular diagnostics," Camblong said, as per News Medical. "SOPHiA facilitates clinical interpretation and its artificial intelligence features give medical experts more time to focus on the study of complex cases. We are already participating in better and faster diagnosing 200 patients every day and we expect SOPHiA's results presented today to dramatically increase this number by allowing clinicians to offer faster and better diagnostics, and patients to benefit from better treatments."
What are your thoughts on the impact of artificial intelligence for data-driven medicine in healthcare? Sound off below and follow Parent Herald for more news and updates.
